Robin A. Buerki
Distinguished in Brain Tumor

Dr. Robin A. Buerki

Neurology
Northwestern Medical Group
15300 West Ave Ste 100, 
Orland Hills, Illinois, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
13 Years of Experience
Distinguished in Brain Tumor
Northwestern Medical Group
15300 West Ave Ste 100, 
Orland Hills, Illinois, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robin Buerki is a Neurologist in Orland Hills, Illinois, Illinois. Dr. Buerki has been practicing medicine for over 13 years and is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.

His clinical research consists of co-authoring 17 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles and participated in 1 clinical trial in the study of Brain Tumor.

Graduate Institution
Northwestern University Feinberg School Of Medicine, 2013.0
Residency
University of Chicago
Specialties
Neurology
Licenses
Psychiatry & Neurology in OH
Board Certifications
American Board Of Psychiatry And Neurology - Neurology (Certified)
Hospital Affiliations
Northwestern Medicine Mchenry
Northwestern Medicine Delnor Community Hospital
Northwestern Medicine Central Dupage Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MetLife
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

15300 West Ave Ste 100, Orland Hills, Illinois, IL 60462
Call: 630-933-6675

Additional Areas of Focus

Dr. Buerki has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Enrollment Status: Recruiting
Publish Date: September 09, 2025
Intervention Type: Drug, Radiation, Biological
Study Drugs: Temozolomide, Lomustine, Regorafenib, Paxalisib, VAL-083
Study Phase: Phase 2/Phase 3
Genomically-Guided Treatment Trial in Brain Metastases
Genomically-Guided Treatment Trial in Brain Metastases
Enrollment Status: Suspended
Publish Date: December 12, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Paxalisib, Entrectinib
Study Phase: Phase 2
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: October 02, 2025
Intervention Type: Other, Biological, Procedure, Drug, Radiation, Device
Study Drugs: Ipilimumab, Nivolumab, Temozolomide
Study Phase: Phase 2/Phase 3
Phase I/II Study of BGB-290 With Temozolomide in Recurrent Gliomas With IDH1/2 Mutations
Phase I/II Study of BGB-290 With Temozolomide in Recurrent Gliomas With IDH1/2 Mutations
Enrollment Status: Completed
Publish Date: January 14, 2025
Intervention Type: Drug, Procedure
Study Drugs: BGB-290 PARP Inhibitor, Temozolomide
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials

17 Total Publications

Building Team Medicine in the Management of CNS Metastases.
Building Team Medicine in the Management of CNS Metastases.
Journal: Journal of clinical medicine
Published: April 13, 2023
View All 17 Publications
Similar Doctors
Roger Stupp
Elite in Brain Tumor
Dr. Roger Stupp
Hematology Oncology | Neurology | Hematology
Elite in Brain Tumor
Dr. Roger Stupp
Hematology Oncology | Neurology | Hematology
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
 (21.8 miles away)
312-695-4360
Experience:
39+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Roger Stupp is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Dr. Stupp has been practicing medicine for over 39 years and is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Brain Tumor.

Rimas V. Lukas
Elite in Brain Tumor
Dr. Rimas V. Lukas
Hematology Oncology | Neurology | Hematology
Elite in Brain Tumor
Dr. Rimas V. Lukas
Hematology Oncology | Neurology | Hematology
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
 (21.8 miles away)
312-695-4360
Experience:
24+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rimas Lukas is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Dr. Lukas has been practicing medicine for over 24 years and is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Astrocytoma, Glioma, Glioblastoma, Brain Tumor, and Gastrostomy.

Elite in Brain Tumor
Dr. Priya U. Kumthekar
Hematology Oncology | Neurology | Hematology
Elite in Brain Tumor
Dr. Priya U. Kumthekar
Hematology Oncology | Neurology | Hematology
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
 (21.8 miles away)
312-695-4360
Experience:
19+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Priya Kumthekar is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Dr. Kumthekar has been practicing medicine for over 19 years and is rated as an Elite provider by MediFind in the treatment of Brain Tumor. Her top areas of expertise are Astrocytoma, Glioblastoma, Brain Tumor, and Glioma.

VIEW MORE BRAIN TUMOR DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Buerki's expertise for a condition
ConditionClose
    • Distinguished
    • Astrocytoma
      Dr. Buerki is
      Distinguished
      . Learn about Astrocytoma.
      See more Astrocytoma experts
    • Atypical Teratoid Rhabdoid Tumor (ATRT)
      Dr. Buerki is
      Distinguished
      . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
      See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
    • Brain Tumor
      Dr. Buerki is
      Distinguished
      . Learn about Brain Tumor.
      See more Brain Tumor experts
    • Embryonal Tumor with Multilayered Rosettes
      Dr. Buerki is
      Distinguished
      . Learn about Embryonal Tumor with Multilayered Rosettes.
      See more Embryonal Tumor with Multilayered Rosettes experts
    • Ependymoma
      Dr. Buerki is
      Distinguished
      . Learn about Ependymoma.
      See more Ependymoma experts
    • Glioblastoma
      Dr. Buerki is
      Distinguished
      . Learn about Glioblastoma.
      See more Glioblastoma experts
    View All 14 Distinguished Conditions
    • Advanced
    • Brain Stem Cancer
      Dr. Buerki is
      Advanced
      . Learn about Brain Stem Cancer.
      See more Brain Stem Cancer experts
    • Gliomatosis Cerebri
      Dr. Buerki is
      Advanced
      . Learn about Gliomatosis Cerebri.
      See more Gliomatosis Cerebri experts
    • Meningioma
      Dr. Buerki is
      Advanced
      . Learn about Meningioma.
      See more Meningioma experts
    • Experienced
    • Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
      Dr. Buerki is
      Experienced
      . Learn about Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.
      See more Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy experts
    • Choroid Plexus Papilloma
      Dr. Buerki is
      Experienced
      . Learn about Choroid Plexus Papilloma.
      See more Choroid Plexus Papilloma experts
    • Diffuse Midline Glioma H3 K27M-Mutant
      Dr. Buerki is
      Experienced
      . Learn about Diffuse Midline Glioma H3 K27M-Mutant.
      See more Diffuse Midline Glioma H3 K27M-Mutant experts
    • Dysembryoplastic Neuroepithelial Tumors (DNET)
      Dr. Buerki is
      Experienced
      . Learn about Dysembryoplastic Neuroepithelial Tumors (DNET).
      See more Dysembryoplastic Neuroepithelial Tumors (DNET) experts
    • Hemangioblastoma
      Dr. Buerki is
      Experienced
      . Learn about Hemangioblastoma.
      See more Hemangioblastoma experts
    • Legius Syndrome
      Dr. Buerki is
      Experienced
      . Learn about Legius Syndrome.
      See more Legius Syndrome experts
    View All 14 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.